French drug-making group Sanofi has reported that net profit slipped in the third quarter but that its main treatments were doing well and research for new drugs including a dengue fever vaccine looked promising. But the price of shares in the group plunged by 7.01 percent in initial trading in response to the news that net profit had fallen by 2.4 percent from the equivalent figure last year to 1.19 billion euros ( (Dollar) 1.51 billion). The company blamed ...
Read More
No comments:
Post a Comment